2017
DOI: 10.1038/bmt.2016.341
|View full text |Cite
|
Sign up to set email alerts
|

Successful haploidentical BMT with post-transplant cyclophosphamide for refractory autoimmune pancytopenia after cord blood transplant in pediatric myelodysplastic syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2019
2019

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 15 publications
0
1
0
Order By: Relevance
“…12 Similarly, Shima reported the combination of TBI with melphalan. 13 The usage of TBI as a part of haploSCT with a PTCY regimen is continued even in patients with Fanconi anemia 14,15 or in combination with busulfan. 16 Some reports in adults have investigated the possibility of a TBI-free conditioning regimen by replacing it with thiotepa and melphalan, but the trial was complicated by limited access to thiotepa and the group reversed to TBI.…”
Section: Discussionmentioning
confidence: 99%
“…12 Similarly, Shima reported the combination of TBI with melphalan. 13 The usage of TBI as a part of haploSCT with a PTCY regimen is continued even in patients with Fanconi anemia 14,15 or in combination with busulfan. 16 Some reports in adults have investigated the possibility of a TBI-free conditioning regimen by replacing it with thiotepa and melphalan, but the trial was complicated by limited access to thiotepa and the group reversed to TBI.…”
Section: Discussionmentioning
confidence: 99%